Parasagittal Meningiomas: Prognostic Factors for Recurrence.

The term parasagittal meningioma applies to those tumors that are associated with the superior sagittal sinus (SSS), originating from the dura mater in close relation to the parasagittal wall or angle, with no intervening brain tissue, possibly extending to the dura of the convexity and/or falx cerebri.(Cushing et al., Meningiomas: their classification, regional behaviour, life history, and surgeical and results. Hafner, 1938) They make up about 20-30% of all meningiomas. There is a vast literature correlating the Simpson grade of resection with later recurrence. Frequent involvement of the superior sagittal sinus (SSS) by these tumors means that the optimal treatment recommended in the literature-complete resection, including of the dural base-is one of the most challenging.

The relationship between vascular endothelial growth factor and histological grade in intracranial meningioma.

BACKGROUND: Meningioma is the most common benign intracranial neoplasm, accounting for 30% of all primary brain tumors. In 90% of cases, meningiomas are benign. Several aspects of molecular biology, including potential biomarkers, have been studied in attempts to better understand the natural history of meningiomas. Vascular endothelial growth factor (VEGF) is a biomarker responsible for inducing physiological and pathological angiogenesis. VEGF expression has been investigated as a potential predictor of several tumor aspects, including growth rate, recurrence rate, brain tissue invasion, peritumoral edema and surgical prognosis, and also as a marker of histological grade. However, there is no consensus in the literature with respect to the association between this biological factor and meningioma. We digitally analyzed immunohistochemical images using ImageJ software with the aim of correlating VEGF expression with tumor histology. METHODS: Tissue samples from patients presenting with meningioma who had undergone surgical removal between 2007 and 2016 at the Hospital de Clínicas de Porto Alegre (HCPA), in Southern Brazil, were analyzed to identify possible immunohistochemical associations between VEGF and histological grade and subtype. RESULTS: Seventy-six patients were included; 82% were female, mean age was 59.9 years (range: 18-91). No statistically significant associations were found between VEGF expression and histological grade or subtype (P = 0.310). CONCLUSION: Our findings suggest that VEGF is frequently present in meningiomas regardless of histological grade and should not be used as a marker of severity or histological grade.